SEC Form 4 · accession 0001127602-19-009098
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Feb 27, 2019
Accepted (ET)
Mar 1, 2019 · 11:13 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 27, 2019 | M | 21,577 | $76.67 | A | 300,777 | D | |
| Common Stock | Feb 27, 2019 | S | 200 | $139.88 | D | 300,577 | D | |
| Common Stock | Feb 27, 2019 | S | 200 | $139.97 | D | 300,377 | D | |
| Common Stock | Feb 27, 2019 | S | 100 | $140.00 | D | 300,277 | D | |
| Common Stock | Feb 27, 2019 | S | 200 | $140.07 | D | 300,077 | D | |
| Common Stock | Feb 27, 2019 | S | 200 | $140.12 | D | 299,877 | D | |
| Common Stock | Feb 27, 2019 | S | 60 | $140.20 | D | 299,817 | D | |
| Common Stock | Feb 27, 2019 | S | 40 | $140.205 | D | 299,777 | D | |
| Common Stock | Feb 27, 2019 | S | 300 | $140.22 | D | 299,477 | D | |
| Common Stock | Feb 27, 2019 | S | 100 | $140.255 | D | 299,377 | D | |
| Common Stock | Feb 27, 2019 | S | 100 | $140.26 | D | 299,277 | D | |
| Common Stock | Feb 27, 2019 | S | 100 | $140.27 | D | 299,177 | D | |
| Common Stock | Feb 27, 2019 | S | 300 | $140.28 | D | 298,877 | D | |
| Common Stock | Feb 27, 2019 | S | 100 | $140.295 | D | 298,777 | D | |
| Common Stock | Feb 27, 2019 | S | 100 | $140.30 | D | 298,677 | D | |
| Common Stock | Feb 27, 2019 | S | 100 | $140.31 | D | 298,577 | D | |
| Common Stock | Feb 27, 2019 | S | 100 | $140.32 | D | 298,477 | D | |
| Common Stock | Feb 27, 2019 | S | 130 | $140.33 | D | 298,347 | D | |
| Common Stock | Feb 27, 2019 | S | 200 | $140.35 | D | 298,147 | D | |
| Common Stock | Feb 27, 2019 | S | 429 | $140.38 | D | 297,718 | D | |
| Common Stock | Feb 27, 2019 | S | 200 | $140.39 | D | 297,518 | D | |
| Common Stock | Feb 27, 2019 | S | 100 | $140.41 | D | 297,418 | D | |
| Common Stock | Feb 27, 2019 | S | 100 | $140.425 | D | 297,318 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $76.67 | Feb 27, 2019 | M | 21,577 | D | Feb 27, 2016 | Feb 27, 2020 | Common Stock | 21,577 | 0 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.